- Home
- BCIC vs TLSA Comparison
BCIC vs TLSA Comparison
Compare BCIC & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCIC
- TLSA
- Stock Information
- Founded
- BCIC 2006
- TLSA 2013
- Country
- BCIC United States
- TLSA United Kingdom
- Employees
- BCIC N/A
- TLSA N/A
- Industry
- BCIC Finance: Consumer Services
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- BCIC Finance
- TLSA Health Care
- Exchange
- BCIC Nasdaq
- TLSA Nasdaq
- Market Cap
- BCIC N/A
- TLSA 187.0M
- IPO Year
- BCIC N/A
- TLSA 2000
- Fundamental
- Price
- BCIC $12.10
- TLSA $1.75
- Analyst Decision
- BCIC
- TLSA
- Analyst Count
- BCIC 0
- TLSA 0
- Target Price
- BCIC N/A
- TLSA N/A
- AVG Volume (30 Days)
- BCIC 68.2K
- TLSA 363.8K
- Earning Date
- BCIC 11-06-2025
- TLSA 05-06-2025
- Dividend Yield
- BCIC 15.54%
- TLSA N/A
- EPS Growth
- BCIC N/A
- TLSA N/A
- EPS
- BCIC N/A
- TLSA N/A
- Revenue
- BCIC $54,317,000.00
- TLSA N/A
- Revenue This Year
- BCIC N/A
- TLSA N/A
- Revenue Next Year
- BCIC N/A
- TLSA N/A
- P/E Ratio
- BCIC N/A
- TLSA N/A
- Revenue Growth
- BCIC N/A
- TLSA N/A
- 52 Week Low
- BCIC $11.48
- TLSA $0.63
- 52 Week High
- BCIC $18.92
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- BCIC N/A
- TLSA 42.44
- Support Level
- BCIC N/A
- TLSA $1.73
- Resistance Level
- BCIC N/A
- TLSA $2.00
- Average True Range (ATR)
- BCIC 0.00
- TLSA 0.15
- MACD
- BCIC 0.00
- TLSA -0.04
- Stochastic Oscillator
- BCIC 0.00
- TLSA 9.30
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.